|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||100.55 - 100.55|
|52-week range||100.55 - 100.55|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||24.17|
|Earnings date||02 Aug 2021 - 06 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
NBIX earnings call for the period ending March 31, 2021.
Neurocrine (NBIX) delivered earnings and revenue surprises of -29.79% and -4.52%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?